Accumulation and expression of serum amyloid P component in human atherosclerotic lesions

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 90-95

  Song, Zhiqing ^a,d   Cai, Lei ^a   Guo, Ling ^a   Tsukamoto, Yoshitane ^b,c   Yutani, Chikao ^b   Li, Xiang An ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d Taian Central Hospital   (China)

Author keywords

ABCA1; Amyloid P component; Cardiovascular disease; Cholesterol efflux; HDL; Pentraxin; Scavenger receptor BI

Indexed keywords

ABC TRANSPORTER A1; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; SERUM AMYLOID P; ABC TRANSPORTER; ABCA1 PROTEIN, HUMAN; CHOLESTEROL; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B;

AORTA INTIMA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; COVALENT BOND; ELECTROIMMUNOASSAY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FIBER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; INTIMA; METABOLISM; PATHOLOGY;

ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; SCAVENGER RECEPTORS, CLASS B; SERUM AMYLOID P-COMPONENT; TUNICA INTIMA; ATP BINDING CASSETTE TRANSPORTER 1;

EID: 77954311874     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.01.046     Document Type: Article

References (19)

1. Gewurz H., Zhang X.-H., Lint T.F. Structure and function of the pentraxins. Curr. Opin. Immunol. 1995, 7:54-64.
2. Manfredi A.A., Rovere-Querini P., Bottazzi B., Garlanda C., Mantovani A. Pentraxins, humoral innate immunity and tissue injury. Curr. Opin. Immunol. 2008, 20:538-544.
3. Emsley J., White H.E., O'Hara B.P., et al. Structure of pentameric human serum amyloid P component. Nature 1994, 367:338-345.
4. Pepys M.B., Baltz M.L., de Beer F.C., et al. Biology of serum amyloid P component. Ann. N Y Acad. Sci. 1982, 389:286-298.
5. Pepys M.B., Dyck R.F., de Beer F.C., Skinner M., Cohen A.S. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin. Exp. Immunol. 1979, 38:284-293.
6. Botto M., Hawkins P.N., Bickerstaff M.C., et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat. Med. 1997, 3:855-859.
7. Breathnach S.M., Kofler H., Sepp N., et al. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 1989, 170:1433-1438.
8. Pepys M.B., Butler P.J. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 1987, 148:308-313.
9. Bickerstaff M.C., Botto M., Hutchinson W.L., et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 1999, 5:694-697.
10. Buckley D.I., Fu R., Freeman M., Rogers K., Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009, 151:483-495.
11. Li X.A., Hatanaka K., Ishibashi-Ueda H., Yutani C., Yamamoto A. Characterization of serum amyloid P component from human aortic atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 1995, 15:252-257.
12. Li X.A., Yutani C., Shimokado K. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein. Biochem. Biophys. Res. Commun. 1998, 244:249-252.
13. Jenny N.S., Arnold A.M., Kuller L.H., Tracy R.P., Psaty B.M. Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 2007, 27:352-358.
14. Stewart C.R., Haw A., Lopez R., et al. Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J. Lipid Res. 2007, 48:2162-2171.
15. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995, 92:1355-1374.
16. Sato M., Sugano N., Ohzono K., et al. Apoptosis and expression of stress protein (ORP150, HO1) during development of ischaemic osteonecrosis in the rat. J. Bone Joint Surg. Br. 2001, 83-B:751-759.
17. van der Westhuyzen D.R., Cai L., de Beer M.C., de Beer F.C. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J. Biol. Chem. 2005, 280:35890-35895.
18. Haidar B., Denis M., Krimbou L., Marcil M., Genest J. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res. 2002, 43:2087-2094.
19. Fournier N., Francone O., Rothblat G., et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 2003, 171:287-293.